Skip to content

MiMedx Group MDXG Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$92.9MBeat by $3.5M
EPS$0.07In line
Revenue estimate$89.4M
EPS estimate$0.07

Next report

Date not yet announced

Financials

Q4 2024

Income statement

See full
Revenue$92.9M+7.0%
Gross profit$76.0M+4.1%
Operating income$11.1M-58.9%
Net income$7.4M-86.1%
EPS (diluted)$0.05-86.5%

Balance sheet

See full
Cash & equivalents$104.4M+27.3%
Total debt$24.8M-51.8%
Total equity$193.1M+35.3%
Total assets$263.9M+10.4%

Cash flow

See full
Operating cash flow$18.8M+83.1%
CapEx$263.0K-38.4%
Free cash flow$18.5M+88.4%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.41B+10.1%
Enterprise value$1.33B+6.4%
P/E33.3×+11.3×
P/S4.1×+0.1×

Profitability

See full
Gross margin82.8%-0.2pp
Operating margin16.9%+5.3pp
Net margin12.2%-6.0pp
FCF margin18.5%+10.8pp

Returns & leverage

See full
Return on equity25.3%
Debt / equity0.1×-0.2×
Current ratio4.2×+0.6×

Versus estimates

Ask the moment MiMedx Group reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MiMedx Group report Q4 2024 earnings?
MiMedx Group (MDXG) reported Q4 2024 earnings on February 26, 2025 after market close.
What were MiMedx Group's Q4 2024 revenue and EPS?
MiMedx Group reported revenue of $92.9M and eps of $0.07 for Q4 2024.
Did MiMedx Group beat estimates in Q4 2024?
Revenue beat the consensus estimate of $89.4M by $3.5M. EPS beat the consensus estimate of $0.07 by $0.00.
Where can I find MiMedx Group's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001376339-25-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.